Repligen | Les Charges D'Exploitation



Operating Expenses Changement Date
Agilent USD 1.37B 63M 2025-04
Align Technology USD 849.42M 1.25M 2025-06
Bio Techne USD 340.82M 63.35M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Bruker USD 785.5M 15.9M 2025-06
Charles River Laboratories USD 899.8M 9.7M 2025-06
Danaher USD 5.18B 718M 2025-06
Dentsply International USD 825M 9M 2025-06
Exact Sciences USD 813.23M 10.44M 2025-06
General Electric Aerospace USD 8.92B 931M 2025-06
Henry Schein USD 5.29B 2.3B 2025-06
Illumina USD 845M 65M 2025-06
IQVIA Holdings USD 3.46B 124M 2025-06
Mettler Toledo International USD 717.51M 35.71M 2025-06
Myriad Genetics USD 224.9M 24.7M 2025-03
Pfizer USD 11.62B 1.58B 2025-06
Repligen USD 176.41M 13.82M 2025-06
Revvity USD 629.52M 36.99M 2025-06
Standard Biotools USD 79.54M 2.85M 2024-12
Thermo Fisher Scientific USD 8.94B 291M 2025-06
Waters USD 583.12M 73.16M 2025-06
West Pharmaceutical Services USD 612.8M 21.8M 2025-06


Repligen Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.